Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813280 · ClinicalTrials.gov registry record
Barriers to the Implementation of Complete Insulin Order Sets
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT00813280: Completed study, sponsored by HealthPartners Institute.
NCT00813280 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00813280 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG \>300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG \>300 mg/dl).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-12 |
What the finished NCT00813280 record still lists
NCT00813280 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00813280 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00813280 about?
NCT00813280 is a clinical study titled "Barriers to the Implementation of Complete Insulin Order Sets". The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG \>300 mg/dL), and whether or not CIO is used (immediately before an...
What is the current status of trial NCT00813280?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-06. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00813280?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia